Personalized and long-term electronic informed consent in clinical research: stakeholder views.

ABSTRACT:

Background

The landscape of clinical research has evolved over the past decade. With technological advances, the practice of using electronic informed consent (eIC) has emerged. However, a number of challenges hinder the successful and widespread deployment of eIC in clinical research. Therefore, we aimed to investigate the views of various stakeholders on the potential advantages and challenges of eIC.

Methods

Semi-structured interviews were conducted with 39 participants from 5 stakeholder groups from across 11 European countries. The stakeholder groups included physicians, patient organization representatives, regulator representatives, ethics committee members, and pharmaceutical industry representatives, and all were involved in clinical research. Interviews were analyz

SUBMITTER: De Sutter E 

PROVIDER: S-EPMC8325412 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature